These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 33150545)

  • 1. Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention.
    Vaswani PA; Tropea TF; Dahodwala N
    Neurotherapeutics; 2020 Oct; 17(4):1724-1735. PubMed ID: 33150545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving the Dial Toward Equity in Parkinson's Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial Participation.
    Adrissi J; Fleisher J
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):475-483. PubMed ID: 35713775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research.
    Indorewalla KK; O'Connor MK; Budson AE; Guess DiTerlizzi C; Jackson J
    J Alzheimers Dis; 2021; 80(3):927-940. PubMed ID: 33612540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.
    Dobkin RD; Amondikar N; Kopil C; Caspell-Garcia C; Brown E; Chahine LM; Marras C; Dahodwala N; Mantri S; Standaert DG; Dean M; Shoulson I; Marek K; Katz A; Korell M; Riley L; Tanner CM;
    J Parkinsons Dis; 2020; 10(2):665-675. PubMed ID: 32250321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for recruitment and retention of underrepresented populations with chronic obstructive pulmonary disease for a clinical trial.
    Huang B; De Vore D; Chirinos C; Wolf J; Low D; Willard-Grace R; Tsao S; Garvey C; Donesky D; Su G; Thom DH
    BMC Med Res Methodol; 2019 Feb; 19(1):39. PubMed ID: 30791871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials.
    Coakley M; Fadiran EO; Parrish LJ; Griffith RA; Weiss E; Carter C
    J Womens Health (Larchmt); 2012 Jul; 21(7):713-6. PubMed ID: 22747427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment and Retention in Clinical Trials of Deep Brain Stimulation in Early-Stage Parkinson's Disease: Past Experiences and Future Considerations.
    Grace Cannard K; Hacker ML; Molinari A; Heusinkveld LE; Currie AD; Charles D
    J Parkinsons Dis; 2018; 8(3):421-428. PubMed ID: 30010145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study.
    Sanchez AV; Ison JM; Hemley H; Willis A; Siddiqi B; Macklin EA; Ulysse C; Reynolds M; Schwarzschild MA; Jackson JD
    Contemp Clin Trials; 2022 Apr; 115():106713. PubMed ID: 35202842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for research participant engagement: A synthetic review and conceptual framework.
    Wong CA; Song WB; Jiao M; O'Brien E; Ubel P; Wang G; Scales CD
    Clin Trials; 2021 Aug; 18(4):457-465. PubMed ID: 34011179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming Barriers to Clinical Trial Enrollment.
    Nipp RD; Hong K; Paskett ED
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():105-114. PubMed ID: 31099636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial.
    Hall DA; Moore C; Comella C;
    Trials; 2018 Nov; 19(1):630. PubMed ID: 30428907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial Participation in Neurodegenerative Diseases: Barriers and Facilitators: A Systematic Review and Meta-Analysis.
    Weemering DN; Beelen A; Kliest T; van Leeuwen LAG; van den Berg LH; van Eijk RPA
    Neurology; 2024 Jul; 103(1):e209503. PubMed ID: 38830181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review.
    Heller C; Balls-Berry JE; Nery JD; Erwin PJ; Littleton D; Kim M; Kuo WP
    Contemp Clin Trials; 2014 Nov; 39(2):169-82. PubMed ID: 25131812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).
    Durant RW; Wenzel JA; Scarinci IC; Paterniti DA; Fouad MN; Hurd TC; Martin MY
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1097-105. PubMed ID: 24643647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
    Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
    Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Engagement of Racial and Ethnic Minorities in HIV Treatment and Vaccine Clinical Trials: A Scoping Review of Literature and Implications for Future Research.
    Bass SB; D'Avanzo P; Alhajji M; Ventriglia N; Trainor A; Maurer L; Eisenberg R; Martinez O
    AIDS Patient Care STDS; 2020 Sep; 34(9):399-416. PubMed ID: 32931317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a cluster-randomized minority recruitment trial: RECRUIT.
    Tilley BC; Mainous AG; Smith DW; McKee MD; Amorrortu RP; Alvidrez J; Diaz V; Ford ME; Fernandez ME; Hauser RA; Singer C; Landa V; Trevino A; DeSantis SM; Zhang Y; Daniels E; Tabor D; Vernon SW
    Clin Trials; 2017 Jun; 14(3):286-298. PubMed ID: 28545336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.